USP22 upregulates ZEB1-mediated VEGFA transcription in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a common solid tumor with high rate of recurrence and mortality. Anti-angiogenesis drugs have been used for the therapy of HCC. However, anti-angiogenic drug resistance commonly occurs during HCC treatment. Thus, identification of a novel VEGFA regulator would be be...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Kai, Xie, Weiwen, Wang, Chunyu, Wang, Shengli, Liu, Wei, Su, Yingjie, Lin, Lin, Zou, Renlong, Sun, Ge, Zhou, Baosheng, Wang, Manlin, Luan, Ruina, Bai, Yu, Huo, Yunlong, Kato, Shigeaki, Zhong, Xinping, Zhao, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008583/
https://www.ncbi.nlm.nih.gov/pubmed/36906615
http://dx.doi.org/10.1038/s41419-023-05699-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008583/
https://www.ncbi.nlm.nih.gov/pubmed/36906615
http://dx.doi.org/10.1038/s41419-023-05699-y

Ejemplares similares